|
© Baupharma. All Rights Reserved 2023. |
At Baupharma, we make it a priority to stay updated with the latest regulatory changes and developments so that our clients are well-informed and prepared for any challenges that may come their way. We value integrity, excellence, and client satisfaction.
Years of Experience
Clients
Pharmacovigilance Experts
Countries
We provide a comprehensive range of services including pharmacovigilance, regulatory affairs, medical writing, and batch release and distribution, ensuring the highest standards of quality and compliance.
Welcome to our exceptional pharmacovigilance services, where we are committed to ensuring the safety and efficacy of medications throughout their lifecycle. With a focus on systematic data collection, assessment, and analysis, we play a crucial role in identifying and managing potential risks associated with drugs. Trust us to provide comprehensive drug safety monitoring solutions to safeguard patient health.
Welcome to our comprehensive Regulatory Affairs service, where we assist companies in navigating the intricate landscape of regulatory compliance and product approval. Our dedicated team of regulatory experts is well-versed in global regulatory requirements, enabling us to provide strategic guidance and support throughout the regulatory process.
At Baupharma, we specialize in crafting accurate and impactful medical content. Our team of medical writers combines scientific expertise with exceptional writing skills to deliver high-quality content that meets your specific needs.
Baupharma has an extensive network of affiliates and partners throughout Europe, so we can efficiently handle all aspects of your supply chain. We offer comprehensive logistics, distribution, and quality assurance (QA) services to meet your needs.
Pharmaceutical companies often handle critical technical documentation, including clinical trial protocols, product labels, and regulatory documents.
Our team of experienced translators and project managers are here to assist you through the whole process.
Featured
The Committee for Veterinary Medicinal Products (CVMP) recently finished its conference, which focused on enhancing animal health and welfare from July 11 to 13, 2023.…
July 14, 2023
Important
In response to an ongoing review, the European Medicines Agency (EMA) has issued a statement regarding GLP-1 receptor agonists. These medications are commonly used in…
July 11, 2023
Featured
The European Medicines Agency (EMA) recently issued an essay outlining the main points of the Pharmacovigilance Risk Assessment Committee (PRAC) conference, which took place from…
July 7, 2023
Featured
The European Medicines Agency (EMA) has officially declared the gradual discontinuation of exceptional regulatory flexibilities that were put in place during the COVID-19 pandemic. These…
July 6, 2023
Featured
The European Medicines Agency (EMA) has released a review highlighting the use of real-world evidence (RWE) in regulatory decision-making. Real-world evidence refers to data collected…
June 23, 2023
We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.
 |
MO - FR 9:00 am - 5:00 pm |
 |
|
 |
|
 |
Czech Republic, |
